Ready to start a GLP-1 weight loss program
The main effect of endogenous GIP regarding weight is primarily on adipose tissue, where it promotes positive energy balance
TRIUMPH-1 (80 weeks, general obesity, n=2,339): 28.3% average weight loss at 12mg dose
According to the company, the newly launched Obeda tablets are designed to provide greater flexibility and treatment choice for people living with chronic metabolic diseases
High temperatures can reduce the effectiveness of GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound
Ask specifically: Does your plan cover Ozempic, and for what indications (diabetes, weight loss, or both)